Iveta C.
- Country
- Slovakia
- Department
- Ambulancia pediatrickej gastroenterologie, hepatologie a vyzivy 1
Research Overview
- C5041010 (APD334-207) An Open Label, Single Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Participants with Moderately to Severely Active Ulcerative Colitis
- Randomized, Double-Blind Study on Clinical Outcomes, Tolerability, and Safety of Oral Pantoprazole in Pediatric Patients with Healed Erosive Esophagitis
Data & Insights
Has run more than one trial at 2 of 19 partner sites.
Specializations
Pediatric Gastroenterology
The investigator specializes in treating digestive system disorders in children and adolescents, with particular emphasis on ulcerative colitis and erosive esophagitis.
- Inflammatory Bowel Disease Management
- Esophageal Disorders
- Adolescent Gastrointestinal Care
Their work focuses on evaluating innovative therapeutic approaches for young patients with moderate to severe gastrointestinal conditions.
Adolescent Medicine
The investigator demonstrates particular expertise in treating gastrointestinal disorders in adolescents aged 12-17 years, addressing both inflammatory conditions and acid-related disorders.
- Age-Specific Treatment Approaches
- Long-term Disease Management
- Therapeutic Safety Assessment
Their research encompasses comprehensive evaluation of treatment outcomes in adolescent populations.
Pediatric Therapeutics
The investigator's work extends to studying targeted therapeutic interventions for pediatric patients across different age groups, from early childhood through adolescence.
- Age-Appropriate Dosing
- Treatment Tolerability
- Clinical Outcomes Assessment
Their focus includes evaluating maintenance therapy effectiveness in pediatric gastrointestinal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.